| Cost-effectiveness analysis in health: a practical approach P Muennig, M Bounthavong John Wiley & Sons, 2016 | 453 | 2016 |
| Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration RC Gale, J Wu, T Erhardt, M Bounthavong, CM Reardon, LJ Damschroder, ... Implementation Science 14, 1-12, 2019 | 439 | 2019 |
| Implementation and preliminary outcomes of a comprehensive oral chemotherapy management clinic SF Wong, M Bounthavong, C Nguyen, K Bechtoldt, E Hernandez American journal of health-system pharmacy 71 (11), 960-965, 2014 | 87 | 2014 |
| Opioid overdose education and naloxone distribution: development of the Veterans Health Administration’s national program EM Oliva, MLD Christopher, D Wells, M Bounthavong, M Harvey, ... Journal of the American Pharmacists Association 57 (2), S168-S179. e4, 2017 | 82 | 2017 |
| Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination MC Hong, DI Hsu, M Bounthavong Infection and drug resistance, 215-223, 2013 | 72 | 2013 |
| Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus (MRSA) complicated skin and soft tissue infection (cSSTI): a meta-analysis M Bounthavong, DI Hsu Current medical research and opinion 26 (2), 407-421, 2010 | 72 | 2010 |
| Cost-effectiveness of treatments for opioid use disorder M Fairley, K Humphreys, VR Joyce, M Bounthavong, J Trafton, A Combs, ... JAMA psychiatry 78 (7), 767-777, 2021 | 71 | 2021 |
| Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: a preliminary analysis M Bounthavong, MA Harvey, DL Wells, SJ Popish, J Himstreet, EM Oliva, ... Journal of the American Pharmacists Association 57 (2), S68-S72, 2017 | 65 | 2017 |
| Revisiting the medication possession ratio threshold for adherence in lipid management JH Watanabe, M Bounthavong, T Chen Current medical research and opinion 29 (3), 175-180, 2013 | 60 | 2013 |
| Implementing a comprehensive, 24-hour emergency department pharmacy program VE Aldridge, HK Park, M Bounthavong, AP Morreale American Journal of Health-System Pharmacy 66 (21), 1943-1947, 2009 | 58 | 2009 |
| Implementation science issues in understanding, collecting, and using cost estimates: a multi-stakeholder perspective AB Eisman, A Quanbeck, M Bounthavong, L Panattoni, RE Glasgow Implementation Science 16 (1), 75, 2021 | 56 | 2021 |
| Cost‐utility analysis of bevacizumab versus ranibizumab in neovascular age‐related macular degeneration using a Markov model JJ Patel, MAS Mendes, M Bounthavong, MLD Christopher, D Boggie, ... Journal of evaluation in clinical practice 18 (2), 247-255, 2012 | 56 | 2012 |
| Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using … M Bounthavong, A Zargarzadeh, DI Hsu, DJ Vanness Value in Health 14 (5), 631-639, 2011 | 55 | 2011 |
| Development and validation of PSPSQ 2.0 measuring patient satisfaction with pharmacist services P Sakharkar, M Bounthavong, JD Hirsch, CM Morello, TC Chen, AV Law Research in Social and Administrative Pharmacy 11 (4), 487-498, 2015 | 51 | 2015 |
| Estimated cost-effectiveness, cost benefit, and risk reduction associated with an endocrinologist-pharmacist diabetes intense medical management “tune-up” clinic JD Hirsch, M Bounthavong, A Arjmand, DR Ha, CL Cadiz, A Zimmerman, ... Journal of Managed Care & Specialty Pharmacy 23 (3), 318-326, 2017 | 46 | 2017 |
| Outcome assessments and cost avoidance of an oral chemotherapy management clinic SF Wong, M Bounthavong, CP Nguyen, T Chen Journal of the National Comprehensive Cancer Network 14 (3), 279-285, 2016 | 39 | 2016 |
| An evaluation of health care expenditures in Crohn's disease using the United States medical expenditure panel survey from 2003 to 2013 M Bounthavong, M Li, JH Watanabe Research in Social and Administrative Pharmacy 13 (3), 530-538, 2017 | 38 | 2017 |
| Cost‐effectiveness analysis of linezolid vs. vancomycin in treating methicillin‐resistant Staphylococcus aureus complicated skin and soft tissue infections using a … M Bounthavong, DI Hsu, MP Okamoto International journal of clinical practice 63 (3), 376-386, 2009 | 38 | 2009 |
| Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model CM Nguyen, M Bounthavong, MAS Mendes, MLD Christopher, JN Tran, ... Pharmacoeconomics 30, 575-593, 2012 | 36 | 2012 |
| Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration M Bounthavong, EB Devine, MLD Christopher, MA Harvey, DL Veenstra, ... Health Services Research 54 (5), 1055-1064, 2019 | 32 | 2019 |
Rashid Kazerooni, PharmD, MS, BCPSAstraZenecaVerified email at merz.com
